In addition, recent studies from our research group have revealed connections between elevated tumor NOS2 and COX-2 co-expression, chronic inflammation, and the development of more aggressive tumor phenotypes in ER- breast cancer [8]. This evidence concerns the gene PTGS2 and breast carcinoma.